Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SangStat Med. (SANG) - 10 of 10 analysts say Strong Buy -- Ignore unavailable to you. Want to Upgrade?

To: Doug who wrote (118)	6/10/1998 1:11:00 PM
From: Richard Haugland	Read Replies (1) \| Respond to of 184

Great press for SANG fnews.yahoo.com Not everyone is jumping on the bandwagon, though. Short sellers (speculators who sell borrowed stock on the bet that it will drop) have built a position of 1.3 million shares as of mid-May. That's only about 11% of float but nearly nine times average daily volume. Between the forthcoming decisions from the FDA and the battle between Wall Street analysts and short sellers, this stock appears destined for a big move in one direction or the other. IMO we may be seeing start of a short squeeze today with stock up now above $31 on relatively heavy volume for the last two days. Let's hope the rise continues for us longs.